Literature DB >> 26085297

Chronic Intermittent Hypoxia Induces Chronic Low-Grade Neuroinflammation in the Dorsal Hippocampus of Mice.

Emilie Sapin1,2, Christelle Peyron3,4, Frédéric Roche5,6, Nadine Gay3,4, Carole Carcenac1,7, Marc Savasta1,7, Patrick Levy1,2,8, Maurice Dematteis1,2,9.   

Abstract

STUDY
OBJECTIVES: Obstructive sleep apnea (OSA) induces cognitive impairment that involves intermittent hypoxia (IH). Because OSA is recognized as a low-grade systemic inflammatory disease and only some patients develop cognitive deficits, we investigated whether IH-related brain consequences shared similar pathophysiology and required additional factors such as systemic inflammation to develop.
DESIGN: Nine-week-old male C57BL/6J mice were exposed to 1 day, 6 or 24 w of IH (alternating 21-5% FiO2 every 30 sec, 8 h/day) or normoxia. Microglial changes were assessed in the functionally distinct dorsal (dH) and ventral (vH) regions of the hippocampus using Iba1 immunolabeling. Then the study concerned dH, as vH only tended to be lately affected. Seven proinflammatory and anti-inflammatory cytokine messenger RNA (mRNA) were assessed at all time points using semiquantitative real-time reverse transcription polymerase chain reaction (RT-PCR). Similar mRNA analysis was performed after 6 w IH or normoxia associated for the past 3 w with repeated intraperitoneal low-dose lipopolysaccharide or saline. MEASUREMENTS AND
RESULTS: Chronic (6, 24 w) but not acute IH induced significant microglial changes in dH only, including increased density and morphological features of microglia priming. In dH, acute but not chronic IH increased IL-1β and RANTES/CCL5 mRNA, whereas the other cytokines remained unchanged. In contrast, chronic IH plus lipopolysaccharide increased interleukin (IL)-6 and IL10 mRNA whereas lipopolysaccharide alone did not affect these cytokines.
CONCLUSION: The obstructive sleep apnea component intermittent hypoxia (IH) causes low-grade neuroinflammation in the dorsal hippocampus of mice, including early but transient cytokine elevations, delayed but long-term microglial changes, and cytokine response alterations to lipopolysaccharide inflammatory challenge. These changes may contribute to IH-induced cognitive impairment and pathological brain aging.
© 2015 Associated Professional Sleep Societies, LLC.

Entities:  

Keywords:  hippocampus; inflammation; intermittent hypoxia; mice; microglia

Mesh:

Substances:

Year:  2015        PMID: 26085297      PMCID: PMC4576327          DOI: 10.5665/sleep.5042

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  77 in total

1.  Decreased neuronal excitability in hippocampal neurons of mice exposed to cyclic hypoxia.

Authors:  X Q Gu; G G Haddad
Journal:  J Appl Physiol (1985)       Date:  2001-09

2.  Monocarboxylate transporter 2 and stroke severity in a rodent model of sleep apnea.

Authors:  Yang Wang; Shang Z Guo; Arend Bonen; Richard C Li; Leila Kheirandish-Gozal; Shelley X L Zhang; Kenneth R Brittian; David Gozal
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

Review 3.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

Review 4.  The immune system and memory consolidation: a role for the cytokine IL-1beta.

Authors:  C Rachal Pugh; M Fleshner; L R Watkins; S F Maier; J W Rudy
Journal:  Neurosci Biobehav Rev       Date:  2001-01       Impact factor: 8.989

Review 5.  Are the dorsal and ventral hippocampus functionally distinct structures?

Authors:  Michael S Fanselow; Hong-Wei Dong
Journal:  Neuron       Date:  2010-01-14       Impact factor: 17.173

Review 6.  The role of cytokines in sleep regulation.

Authors:  James M Krueger
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

7.  Intracerebroventricular but not intravenous interleukin-1beta induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation.

Authors:  M G Proescholdt; S Chakravarty; J A Foster; S B Foti; E M Briley; M Herkenham
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 8.  Cardiovascular consequences of sleep-disordered breathing: contribution of animal models to understanding the human disease.

Authors:  Maurice Dematteis; Diane Godin-Ribuot; Claire Arnaud; Christophe Ribuot; Françoise Stanke-Labesque; Jean-Louis Pépin; Patrick Lévy
Journal:  ILAR J       Date:  2009

9.  The changing phenotype of microglia from homeostasis to disease.

Authors:  Xiao-Guang Luo; Sheng-Di Chen
Journal:  Transl Neurodegener       Date:  2012-04-24       Impact factor: 8.014

Review 10.  Toll-like receptor-4 mediated inflammation is involved in the cardiometabolic alterations induced by intermittent hypoxia.

Authors:  Laureline Poulain; Vincent Richard; Patrick Lévy; Maurice Dematteis; Claire Arnaud
Journal:  Mediators Inflamm       Date:  2015-03-19       Impact factor: 4.711

View more
  29 in total

1.  The association of sleep-disordered breathing and white matter hyperintensities in heart failure patients.

Authors:  Chooza Moon; Barbara B Bendlin; Kelsey E Melah; Lisa C Bratzke
Journal:  Metab Brain Dis       Date:  2018-09-14       Impact factor: 3.584

2.  Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy.

Authors:  Susan B Gurley; Sujoy Ghosh; Stacy A Johnson; Kengo Azushima; Rashidah Binte Sakban; Simi E George; Momoe Maeda; Timothy W Meyer; Thomas M Coffman
Journal:  Diabetes       Date:  2018-07-31       Impact factor: 9.461

3.  Intermittent Hypoxia Disrupts Adult Neurogenesis and Synaptic Plasticity in the Dentate Gyrus.

Authors:  Maggie A Khuu; Chelsea M Pagan; Thara Nallamothu; Robert F Hevner; Rebecca D Hodge; Jan-Marino Ramirez; Alfredo J Garcia
Journal:  J Neurosci       Date:  2018-12-26       Impact factor: 6.167

Review 4.  Sex differences in sleep apnea and comorbid neurodegenerative diseases.

Authors:  Brina Snyder; Rebecca L Cunningham
Journal:  Steroids       Date:  2017-12-16       Impact factor: 2.668

5.  The Study of Neurocognitive Outcomes, Radiological and Retinal Effects of Aspirin in Sleep Apnoea- rationale and methodology of the SNORE-ASA study.

Authors:  Stephanie Alison Ward; Elsdon Storey; Robyn L Woods; Garun S Hamilton; Ryo Kawasaki; Andrew L Janke; Matthew T Naughton; Fergal O'Donoghue; Rory Wolfe; Tien Y Wong; Christopher M Reid; Walter P Abhayaratna; Nigel Stocks; Ruth Trevaks; Sharyn Fitzgerald; Lauren A B Hodgson; Liubov Robman; Barbara Workman; John J McNeil
Journal:  Contemp Clin Trials       Date:  2017-10-31       Impact factor: 2.226

6.  Prebiotics, Probiotics, and Acetate Supplementation Prevent Hypertension in a Model of Obstructive Sleep Apnea.

Authors:  Bhanu P Ganesh; James W Nelson; Joshua R Eskew; Arunkumar Ganesan; Nadim J Ajami; Joseph F Petrosino; Robert M Bryan; David J Durgan
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

7.  Cerebral and Muscle Oxygenation During Intermittent Hypoxia Exposure in Healthy Humans.

Authors:  Thomas Rupp; Arthur Peyrard; Renaud Tamisier; Jean-Louis Pepin; Samuel Verges
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

Review 8.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-06-01

9.  Electrophysiological and neuropsychological outcomes of severe obstructive sleep apnea: effects of hypoxemia on cognitive performance.

Authors:  Deniz Yerlikaya; Derya Durusu Emek-Savaş; Behice Bircan Kurşun; İbrahim Öztura; Görsev G Yener
Journal:  Cogn Neurodyn       Date:  2018-05-25       Impact factor: 5.082

Review 10.  Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity.

Authors:  Abdelnaby Khalyfa; Leila Kheirandish-Gozal; David Gozal
Journal:  Respir Physiol Neurobiol       Date:  2017-07-01       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.